. Author manuscript; available in PMC: 2022 Jul 14.

Published in final edited form as: Epilepsia. 2020 May 18;61(6):e66–e70. doi: 10.1111/epi.16534

Table 1:

Logistic regression models of the probability of success using weight, treatment and sex with all interactions (weight ≤ 75 kg as reference group) (n=235)

Weight-group	Treatment	Sex	Using primary outcome as dependent variable Adjusted Odds Ratio (95% confidence interval)	Using clinical seizure cessation without additional antiseizure medication as dependent variable Adjusted Odds Ratio (95% confidence interval)
> 75 kg	Fosphenytoin	Male	0.71 (0.20, 2.55)	0.56 (0.14, 2.26)
> 75 kg	Fosphenytoin	Female	1.13 (0.26, 4.94)	1.16 (0.27, 5.05)
> 75 kg	Levetiracetam	Male	0.82 (0.26, 2.56)	0.47 (0.15, 1.49)
> 75 kg	Levetiracetam	Female	1.70 (0.45, 6.44)	1.08 (0.29, 4.08)
> 75 kg	Valproic acid	Male	0.83 (0.26, 2.66)	0.72 (0.22, 2.40)
> 75 kg	Valproic acid	Female	0.64 (0.14, 2.91)	0.49 (0.11, 2.20)